"Immunization program"

#6279414

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279416

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279418

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279420

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279422

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279424

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279426

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6279428

18 December 2020

Health Worker of the Kebayoran Lama Community Health Center conducts a child development check in the Bungur area, Jakarta, Indonesia, on December 16, 2020. This activity is one of the stunting prevention programs, to see the nutrional status of children under five in terms of comorbidities or environmental conditions, nutrition, immunization, and history pregnancy.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274256

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274258

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274260

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274262

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274264

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274266

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274270

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#6274272

14 December 2020

Photo illustration of a medical syringe with a needle seen in front of the Moderna pharmaceutical corporation logo. Moderna expects the American decision, an approval for emergency use, the vaccine candidate mRNA-1273 on December 17 2020 from the FDA and European approval for COVID-19 vaccine in January of 2021. Moderna is an American biotechnology company based in Cambridge, Massachusetts developing vaccine technologies based on messenger RNA mRNA. The Coronavirus pandemic, one of the biggest healthcare crisis in the world will result in the largest vaccination program in human history. Amsterdam, the Netherlands on December 14, 2020

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.